Braveheart Bio, Inc. (BRVE)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 13 signals for Braveheart Bio, Inc.. Most notable: 2026-08-07: Forbion Growth Opportunities Fund III Cooperatief U.A.; Forbion Growth III Management B.V.; Forbion Ventures Fund VII Cooperatief U.A.; Forbion Ventures VII Management B.V. (ten_percent_owner) bought $34.6M of stock; 2026-08-07: Chimovits Erez (director) bought $30.0M of stock; 2026-08-07: ORBIMED ADVISORS LLC; OrbiMed Capital GP IX LLC; OrbiMed Genesis GP LLC (director) bought $30.0M of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Insider purchaseForbion Growth Opportunities Fund III Cooperatief U.A.; Forbion Growth III Management B.V.; Forbion Ventures Fund VII Cooperatief U.A.; Forbion Ventures VII Management B.V. (ten_percent_owner) bought $34.6M of stock
- Insider purchaseForbion Growth Opportunities Fund III Cooperatief U.A.; Forbion Growth III Management B.V.; Forbion Ventures Fund VII Cooperatief U.A.; Forbion Ventures VII Management B.V. (ten_percent_owner) bought $30.2M of stock
- Insider purchaseChimovits Erez (director) bought $30.0M of stock
- Insider purchaseORBIMED ADVISORS LLC; OrbiMed Capital GP IX LLC; OrbiMed Genesis GP LLC (director) bought $30.0M of stock
- Insider buying cluster9 insiders bought $159.0M within 14 days
- Insider purchaseAH Bio Fund IV, L.P.; AH Equity Partners Bio IV, L.L.C.; Andreessen Marc L; HOROWITZ BENJAMIN A (ten_percent_owner) bought $19.8M of stock
- Insider purchaseORBIMED ADVISORS LLC; OrbiMed Capital GP IX LLC; OrbiMed Genesis GP LLC (director) bought $4.9M of stock
- Insider purchaseChimovits Erez (director) bought $4.9M of stock
- Insider purchaseMurdoch Travis (director) bought $1.5M of stock
- Insider purchaseViehbacher Christopher (director) bought $1.5M of stock
- Insider purchaseLubner David Charles (director) bought $1000k of stock
- Insider purchaseRickey James Paul (officer) bought $500k of stock
- Insider purchaseMalek David I (director) bought $75k of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-08-07 | AH Bio Fund IV, L.P.; AH Equity Partners Bio IV, L.L.C.; Andreessen Marc L; HOROWITZ BENJAMIN A | ten percent owner | C | 9,132,420 | — | — |
| 2026-08-07 | AH Bio Fund IV, L.P.; AH Equity Partners Bio IV, L.L.C.; Andreessen Marc L; HOROWITZ BENJAMIN A | ten percent owner | P | 1,100,000 | 18 | $19,800,000 |
| 2026-08-07 | Chimovits Erez | director | C | 9,132,420 | — | — |
| 2026-08-07 | Chimovits Erez | director | P | 1,666,667 | 18 | $30,000,006 |
| 2026-08-07 | Chimovits Erez | director | P | 273,333 | 18 | $4,919,994 |
| 2026-08-07 | ORBIMED ADVISORS LLC; OrbiMed Capital GP IX LLC; OrbiMed Genesis GP LLC | director | C | 9,132,420 | — | — |
| 2026-08-07 | ORBIMED ADVISORS LLC; OrbiMed Capital GP IX LLC; OrbiMed Genesis GP LLC | director | P | 1,666,667 | 18 | $30,000,006 |
| 2026-08-07 | ORBIMED ADVISORS LLC; OrbiMed Capital GP IX LLC; OrbiMed Genesis GP LLC | director | P | 273,333 | 18 | $4,919,994 |
| 2026-08-07 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ten percent owner | C | 7,420,091 | — | — |
| 2026-08-07 | Forbion Growth Opportunities Fund III Cooperatief U.A.; Forbion Growth III Management B.V.; Forbion Ventures Fund VII Cooperatief U.A.; Forbion Ventures VII Management B.V. | ten percent owner | C | 9,132,420 | 0 | $0 |
| 2026-08-07 | Forbion Growth Opportunities Fund III Cooperatief U.A.; Forbion Growth III Management B.V.; Forbion Ventures Fund VII Cooperatief U.A.; Forbion Ventures VII Management B.V. | ten percent owner | C | 7,990,867 | 0 | $0 |
| 2026-08-07 | Forbion Growth Opportunities Fund III Cooperatief U.A.; Forbion Growth III Management B.V.; Forbion Ventures Fund VII Cooperatief U.A.; Forbion Ventures VII Management B.V. | ten percent owner | P | 1,920,000 | 18 | $34,560,000 |
| 2026-08-07 | Forbion Growth Opportunities Fund III Cooperatief U.A.; Forbion Growth III Management B.V.; Forbion Ventures Fund VII Cooperatief U.A.; Forbion Ventures VII Management B.V. | ten percent owner | P | 1,680,000 | 18 | $30,240,000 |
| 2026-08-07 | Rickey James Paul | officer | P | 27,777 | 18 | $499,986 |
| 2026-08-07 | Viehbacher Christopher | director | P | 83,333 | 18 | $1,499,994 |
| 2026-08-07 | Malek David I | director | P | 4,166 | 18 | $74,988 |
| 2026-08-07 | Anderson Michele A. | officer | P | 1,111 | 18 | $19,998 |
| 2026-08-07 | Murdoch Travis | director | P | 83,333 | 18 | $1,499,994 |
| 2026-08-07 | Lubner David Charles | director | P | 55,555 | 18 | $999,990 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-10 SCHEDULE 13D/A
- 2026-09-08 8-K
- 2026-09-08 10-Q
- 2026-08-18 SCHEDULE 13D
- 2026-08-14 3
- 2026-08-14 SCHEDULE 13D
- 2026-08-14 SCHEDULE 13G
- 2026-08-11 4
- 2026-08-11 4
- 2026-08-11 4
- 2026-08-10 4
- 2026-08-07 4
- 2026-08-07 4
- 2026-08-07 4
- 2026-08-07 4
- 2026-08-07 4
- 2026-08-07 4
- 2026-08-07 4
- 2026-08-07 4
- 2026-08-07 4